标题
Sirtuin 2 mutations in human cancers impair its function in genome maintenance
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 292, Issue 24, Pages 9919-9931
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2017-05-02
DOI
10.1074/jbc.m116.772566
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- SIRT2 orchestrates the DNA damage response
- (2016) Hui Zhang et al. CELL CYCLE
- ATRIP Deacetylation by SIRT2 Drives ATR Checkpoint Activation by Promoting Binding to RPA-ssDNA
- (2016) Hui Zhang et al. Cell Reports
- The expression levels of the sirtuins in patients with BCC
- (2015) Metin Temel et al. TUMOR BIOLOGY
- Selective Sirt2 inhibition by ligand-induced rearrangement of the active site
- (2015) Tobias Rumpf et al. Nature Communications
- Deacetylation of the mitotic checkpoint protein BubR1 at lysine 250 by SIRT2 and subsequent effects on BubR1 degradation during the prometaphase/anaphase transition
- (2014) Tomohisa Suematsu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CHD7 Expression Predicts Survival Outcomes in Patients with Resected Pancreatic Cancer
- (2014) L. E. Colbert et al. CANCER RESEARCH
- Sirtuins, metabolism, and DNA repair
- (2014) Jee-Eun Choi et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- SIRT2 induces the checkpoint kinase BubR1 to increase lifespan
- (2014) B. J. North et al. EMBO JOURNAL
- COSMIC: exploring the world's knowledge of somatic mutations in human cancer
- (2014) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response
- (2014) Scott C. Smith et al. NUCLEIC ACIDS RESEARCH
- UniProt: a hub for protein information
- (2014) NUCLEIC ACIDS RESEARCH
- SIRT1 and SIRT2: emerging targets in neurodegeneration
- (2013) Gizem Donmez et al. EMBO Molecular Medicine
- The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation
- (2013) L. Serrano et al. GENES & DEVELOPMENT
- ConSurf: Using Evolutionary Data to Raise Testable Hypotheses about Protein Function
- (2013) Gershon Celniker et al. ISRAEL JOURNAL OF CHEMISTRY
- Regulation of SIRT2 levels for human non-small cell lung cancer therapy
- (2013) Ziming Li et al. LUNG CANCER
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer
- (2013) W A Hall et al. ONCOGENE
- SIRT2 directs the replication stress response through CDK9 deacetylation
- (2013) H. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity
- (2011) Hyun-Seok Kim et al. CANCER CELL
- Sirtuins, Aging, and Medicine
- (2011) Leonard Guarente NEW ENGLAND JOURNAL OF MEDICINE
- A method and server for predicting damaging missense mutations
- (2010) Ivan A Adzhubei et al. NATURE METHODS
- ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids
- (2010) H. Ashkenazy et al. NUCLEIC ACIDS RESEARCH
- Recent progress in the biology and physiology of sirtuins
- (2009) Toren Finkel et al. NATURE
- Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
- (2009) Prateek Kumar et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started